Stay updated
with us
Medicines360 is constantly evolving, and we want to keep you informed about our latest projects, partnerships, and achievements.
News
Learn more about significant announcements and developments at Medicines360 and the impact we are making in the field of women’s health.
-
Medicines360 Appoints Erica Rogers to Board of Directors
-
Medicines360 and DKT WomanCare Announce Strategic Partnership to Expand Access to the Hormonal IUD Avibela™
-
Medicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Health
-
Exploring Control in Contraceptive Use: Perspectives on IUD Self-Removal
-
FDA Approves Medicines360’s Supplemental New Drug Application for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg as Treatment of Heavy Menstrual Bleeding
-
Medicines360 Appoints Andrea Olariu, MD, PhD as Chief Executive Officer
